{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T04:29:55Z","timestamp":1793248195902,"version":"4.5.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"vor","delay-in-days":1461,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.kint.2021.03.013","type":"journal-article","created":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T20:03:42Z","timestamp":1617048222000},"page":"1296-1302","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["APOL1 at 10 years: progress and next steps"],"prefix":"10.1016","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0275-5530","authenticated-orcid":false,"given":"Barry I.","family":"Freedman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey B.","family":"Kopp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9560-076X","authenticated-orcid":false,"given":"Matthew G.","family":"Sampson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1005-3726","authenticated-orcid":false,"given":"Katalin","family":"Susztak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2021.03.013_bib1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.molbiopara.2004.07.004","article-title":"Characterization of primate trypanosome lytic factors","volume":"138","author":"Lugli","year":"2004","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.kint.2021.03.013_bib2","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1073\/pnas.1421953112","article-title":"Human trypanolytic factor APOL1 forms pH-gated cation-selective channels in planar lipid bilayers: relevance to trypanosome lysis","volume":"112","author":"Thomson","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.kint.2021.03.013_bib3","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.1016\/j.celrep.2020.02.064","article-title":"APOL1 C-terminal variants may trigger kidney disease through interference with APOL3 control of actomyosin","volume":"30","author":"Uzureau","year":"2020","journal-title":"Cell Rep"},{"key":"10.1016\/j.kint.2021.03.013_bib4","first-page":"278","article-title":"Joint associations of maternal-fetal APOL1 genotypes and maternal country of origin with preeclampsia risk","volume":"5","author":"Hong","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2021.03.013_bib5","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1681\/ASN.2014111131","article-title":"Integrative genomics identifies novel associations with APOL1 risk genotypes\u00a0in Black NEPTUNE subjects","volume":"27","author":"Sampson","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2021.03.013_bib6","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/ndt\/gfw451","article-title":"A\u00a0null variant in the apolipoprotein L3 gene is associated with non-diabetic nephropathy","volume":"33","author":"Skorecki","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2021.03.013_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0211559","article-title":"APOL1 renal risk variants promote cholesterol accumulation in tissues and cultured macrophages from APOL1 transgenic mice","volume":"14","author":"Ryu","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2021.03.013_bib8","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/s42003-018-0188-2","article-title":"APOL1 risk allele RNA contributes to renal toxicity by activating protein kinase R","volume":"1","author":"Okamoto","year":"2018","journal-title":"Commun Biol"},{"key":"10.1016\/j.kint.2021.03.013_bib9","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1073\/pnas.1716113115","article-title":"UBD modifies APOL1-induced kidney disease risk","volume":"115","author":"Zhang","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.kint.2021.03.013_bib10","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.51185","article-title":"Apolipoprotein L-1 renal risk variants form active channels at the plasma membrane driving cytotoxicity","volume":"9","author":"Giovinazzo","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.kint.2021.03.013_bib11","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.semnephrol.2015.04.008","article-title":"APOL1 kidney disease risk variants: an evolving landscape","volume":"35","author":"Dummer","year":"2015","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.kint.2021.03.013_bib12","doi-asserted-by":"crossref","first-page":"F326","DOI":"10.1152\/ajprenal.00647.2013","article-title":"APOL1 risk variants enhance podocyte necrosis through compromising lysosomal membrane permeability","volume":"307","author":"Lan","year":"2014","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.kint.2021.03.013_bib13","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nm.4287","article-title":"Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice","volume":"23","author":"Beckerman","year":"2017","journal-title":"Nat Med"},{"key":"10.1016\/j.kint.2021.03.013_bib14","doi-asserted-by":"crossref","first-page":"15485","DOI":"10.1038\/s41598-019-51998-w","article-title":"Nucleosomal dsDNA stimulates APOL1 expression in human cultured podocytes by activating the cGAS\/IFI16-STING signaling pathway","volume":"9","author":"Davis","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.kint.2021.03.013_bib15","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1186\/s12882-020-01995-3","article-title":"APOL1 renal risk variants exacerbate podocyte injury by increasing inflammatory stress","volume":"21","author":"Wakashin","year":"2020","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.kint.2021.03.013_bib16","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1681\/ASN.2020010079","article-title":"Kidney disease-associated APOL1 variants have dose-dependent, dominant toxic gain-of-function","volume":"31","author":"Datta","year":"2020","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2021.03.013_bib17","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.1073\/pnas.1820414116","article-title":"Recruitment of APOL1 kidney disease risk variants to lipid droplets attenuates cell toxicity","volume":"116","author":"Chun","year":"2019","journal-title":"Proc Natl Acad Sci U\u00a0S A"},{"key":"10.1016\/j.kint.2021.03.013_bib18","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.semnephrol.2017.07.008","article-title":"APOL1 nephrotoxicity: what does ion transport have to do with it?","volume":"37","author":"Olabisi","year":"2017","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.kint.2021.03.013_bib19","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1681\/ASN.2016111220","article-title":"Intracellular APOL1 risk variants cause cytotoxicity accompanied by energy depletion","volume":"28","author":"Granado","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2021.03.013_bib20","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1681\/ASN.2019020114","article-title":"APOL1 kidney risk variants induce cell death via mitochondrial translocation and opening of the mitochondrial permeability transition pore","volume":"30","author":"Shah","year":"2019","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2021.03.013_bib21","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1681\/ASN.2016050567","article-title":"APOL1 renal-risk variants induce mitochondrial dysfunction","volume":"28","author":"Ma","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2021.03.013_bib22","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/ki.2014.270","article-title":"Innate immunity pathways regulate the nephropathy gene apolipoprotein L1","volume":"87","author":"Nichols","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2021.03.013_bib23","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/nm.4362","article-title":"A\u00a0tripartite complex of suPAR, APOL1 risk variants and alphavbeta3 integrin on podocytes mediates chronic kidney disease","volume":"23","author":"Hayek","year":"2017","journal-title":"Nat Med"},{"key":"10.1016\/j.kint.2021.03.013_bib24","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1126\/science.1114566","article-title":"Apolipoprotein L-I promotes trypanosome lysis by forming pores in lysosomal membranes","volume":"309","author":"Perez-Morga","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.kint.2021.03.013_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004903","article-title":"A\u00a0primate APOL1 variant that kills Trypanosoma brucei gambiense","volume":"10","author":"Cooper","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.kint.2021.03.013_bib26","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/s41586-020-2859-7","article-title":"High-depth African genomes inform human migration and health","volume":"586","author":"Choudhury","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.kint.2021.03.013_bib27","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ajhg.2013.05.014","article-title":"Identifying Darwinian selection acting on different human APOL1 variants among diverse African populations","volume":"93","author":"Ko","year":"2013","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.kint.2021.03.013_bib28","first-page":"2423","article-title":"Renal microvascular susceptibility in African American pedigrees","volume":"25","author":"Freedman","year":"1993","journal-title":"Transplant Proc"},{"key":"10.1016\/j.kint.2021.03.013_bib29","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0272-6386(12)80266-6","article-title":"The familial risk of end-stage renal disease in African Americans","volume":"21","author":"Freedman","year":"1993","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2021.03.013_bib30","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0272-6386(95)90001-2","article-title":"The link between hypertension and nephrosclerosis","volume":"25","author":"Freedman","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2021.03.013_bib31","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1193032","article-title":"Association of trypanolytic ApoL1 variants with kidney disease in African Americans","volume":"329","author":"Genovese","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.kint.2021.03.013_bib32","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00439-010-0861-0","article-title":"Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene","volume":"128","author":"Tzur","year":"2010","journal-title":"Hum Genet"},{"key":"10.1016\/j.kint.2021.03.013_bib33","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1681\/ASN.2010070730","article-title":"The apolipoprotein L1 (APOL1) gene and nondiabetic nephropathy in African Americans","volume":"21","author":"Freedman","year":"2010","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2021.03.013_bib34","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/ckj\/sfx029","article-title":"Collapsing glomerulopathy: a 30-year perspective and single, large center experience","volume":"10","author":"Nicholas Cossey","year":"2017","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.kint.2021.03.013_bib35","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nrneph.2015.172","article-title":"Hypertension-attributed nephropathy: what's in a name?","volume":"12","author":"Freedman","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2021.03.013_bib36","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1681\/ASN.2012121180","article-title":"Apolipoprotein L1 risk variants associate with systemic lupus erythematosus-associated collapsing glomerulopathy","volume":"24","author":"Larsen","year":"2013","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2021.03.013_bib37","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1365-2141.2011.08832.x","article-title":"MYH9 and APOL1 are both associated with sickle cell disease nephropathy","volume":"155","author":"Ashley-Koch","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.kint.2021.03.013_bib38","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/art.38220","article-title":"End-stage renal disease in African Americans with lupus nephritis is associated with APOL1","volume":"66","author":"Freedman","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.kint.2021.03.013_bib39","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.semnephrol.2017.07.006","article-title":"Apolipoprotein L1 gene effects on kidney transplantation","volume":"37","author":"Freedman","year":"2017","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.kint.2021.03.013_bib40","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1681\/ASN.2020050558","article-title":"AKI and collapsing glomerulopathy associated with COVID-19 and APOL 1 high-risk genotype","volume":"31","author":"Wu","year":"2020","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2021.03.013_bib41","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41581-020-0332-3","article-title":"COVAN is the new HIVAN: the re-emergence of collapsing glomerulopathy with COVID-19","volume":"16","author":"Velez","year":"2020","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2021.03.013_bib42","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1681\/ASN.2014050469","article-title":"APOL1 risk variants are strongly associated with HIV-associated nephropathy in Black South Africans","volume":"26","author":"Kasembeli","year":"2015","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2021.03.013_bib43","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ajhg.2018.08.002","article-title":"Fetal-not maternal-APOL1 genotype associated with risk for preeclampsia in those with African ancestry","volume":"103","author":"Reidy","year":"2018","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.kint.2021.03.013_bib44","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.kint.2020.01.027","article-title":"Phenome-wide association analysis suggests the APOL1 linked disease spectrum primarily drives kidney-specific pathways","volume":"97","author":"Bajaj","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2021.03.013_bib45","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12881-020-01048-4","article-title":"Association of preeclampsia with infant APOL1 genotype in African Americans","volume":"21","author":"Miller","year":"2020","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.kint.2021.03.013_bib46","first-page":"983","article-title":"APOL1-associated glomerular disease among African-American children: a collaboration of the Chronic Kidney Disease in Children (CKiD) and Nephrotic Syndrome Study Network (NEPTUNE) cohorts","volume":"32","author":"Ng","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2021.03.013_bib47","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1681\/ASN.2019030240","article-title":"APOL1 kidney risk variants and cardiovascular disease: an individual participant data meta-analysis","volume":"30","author":"Grams","year":"2019","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2021.03.013_bib48","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1161\/CIRCULATIONAHA.118.036589","article-title":"Association of APOL1 risk alleles with cardiovascular disease in Blacks in the Million Veteran Program","volume":"140","author":"Bick","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.kint.2021.03.013_bib49","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1681\/ASN.2019080830","article-title":"Domain-specific antibodies reveal differences in the membrane topologies of apolipoprotein L1 in serum and podocytes","volume":"31","author":"Gupta","year":"2020","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2021.03.013_bib50","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1681\/ASN.2019080829","article-title":"Apolipoprotein L1-specific antibodies detect endogenous APOL1 inside the endoplasmic reticulum and on the plasma membrane of podocytes","volume":"31","author":"Scales","year":"2020","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2021.03.013_bib51","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.kint.2019.07.010","article-title":"Apolipoprotein L1 (APOL1) risk variant toxicity depends on the haplotype background","volume":"96","author":"Lannon","year":"2019","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2021.03.013_bib52","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41572-020-0196-7","volume":"6","author":"Kopp","year":"2020","journal-title":"Podocytopathies. Nat Rev Dis Primers."},{"key":"10.1016\/j.kint.2021.03.013_bib53","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.molmed.2018.05.008","article-title":"APOL1: the balance imposed by infection, selection, and kidney disease","volume":"24","author":"Beckerman","year":"2018","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.kint.2021.03.013_bib54","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1073\/pnas.1522913113","article-title":"APOL1 kidney disease risk variants cause cytotoxicity by depleting cellular potassium and inducing stress-activated protein kinases","volume":"113","author":"Olabisi","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.kint.2021.03.013_bib55","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1053\/j.ajkd.2018.06.020","article-title":"APOL1-associated nephropathy: a key contributor to racial disparities in CKD","volume":"72","author":"Freedman","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2021.03.013_bib56","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/j.kint.2018.01.026","article-title":"Plasma biomarkers are associated with renal outcomes in individuals with APOL1 risk variants","volume":"93","author":"Nadkarni","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2021.03.013_bib57","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/ki.2013.173","article-title":"JC polyoma virus interacts with APOL1 in African Americans with nondiabetic nephropathy","volume":"84","author":"Divers","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2021.03.013_bib58","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1210\/jc.2018-02482","article-title":"JC viruria is associated with reduced risk of diabetic kidney disease","volume":"104","author":"Kruzel-Davila","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.kint.2021.03.013_bib59","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1681\/ASN.2011040388","article-title":"APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy","volume":"22","author":"Kopp","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2021.03.013_bib60","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2215\/CJN.11921019","article-title":"Association of APOL1 risk genotype and air pollution for kidney disease","volume":"15","author":"Paranjpe","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2021.03.013_bib61","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.kint.2018.03.017","article-title":"Genome-wide association studies suggest that APOL1-environment interactions more likely trigger kidney disease in African Americans with nondiabetic nephropathy than\u00a0strong APOL1-second gene interactions","volume":"94","author":"Langefeld","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2021.03.013_bib62","doi-asserted-by":"crossref","first-page":"126","DOI":"10.2215\/CJN.01810219","article-title":"Genetic testing for APOL1 genetic variants in clinical practice: finally starting to arrive","volume":"15","author":"Kopp","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2021.03.013_bib63","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ekir.2019.11.022","article-title":"APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO): design and rationale","volume":"5","author":"Freedman","year":"2020","journal-title":"Kidney Int Rep"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253821003008?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253821003008?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T01:00:49Z","timestamp":1758762049000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253821003008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":63,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0085253821003008"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2021.03.013","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"APOL1 at 10 years: progress and next steps","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2021.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}